Anti-CD20 monoclonal antibody
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Anti-CD20 monoclonal antibody, covering 2017-11-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]